Talis Biomedical's market cap is currently $52.76M. The company's EPS TTM is $-28.018; its P/E ratio is ―; Talis Biomedical is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 412.00K	$ 3.65M	$ 0.00	$ 10.94M	$ 3.98M
Gross Profit	$ 371.00K	$ -4.74M	$ -2.62M	$ 10.94M	$ 3.98M
Operating Income	$ -66.81M	$ -115.14M	$ -191.82M	$ -91.18M	$ -26.70M
EBITDA	$ -66.05M	$ -106.31M	$ -191.82M	$ -90.42M	$ -25.97M
Net Income	$ -62.01M	$ -110.89M	$ -190.46M	$ -91.08M	$ -27.43M
Balance Sheet
Cash & Short-Term Investments	$ 76.73M	$ 130.19M	$ 232.54M	$ 138.48M	$ 21.60M
Total Assets	$ 94.67M	$ 169.29M	$ 265.83M	$ 198.41M	$ 25.73M
Total Debt	$ 19.67M	$ 33.58M	$ 13.98M	$ 693.00K	$ 0.00
Net Debt	$ -57.06M	$ -96.61M	$ -218.57M	$ -137.79M	$ -21.60M
Total Liabilities	$ 25.56M	$ 42.55M	$ 31.85M	$ 306.98M	$ 46.87M
Stockholders' Equity	$ 69.12M	$ 126.74M	$ 233.98M	$ -108.57M	$ -21.14M
Cash Flow
Free Cash Flow	$ -53.73M	$ -101.75M	$ -174.25M	$ -95.22M	$ -24.90M
Operating Cash Flow	$ -53.24M	$ -100.14M	$ -171.38M	$ -87.02M	$ -24.33M
Investing Cash Flow	$ -486.00K	$ -1.61M	$ -2.87M	$ -8.20M	$ -578.00K
Financing Cash Flow	$ 33.00K	$ 406.00K	$ 234.43M	$ 246.75M	$ 39.61M

Currency in USD

Talis Biomedical Earnings and Revenue History

Income Statement >

Talis Biomedical Debt to Assets

Balance Sheet >

Talis Biomedical Cash Flow

Cash Flow >

Talis Biomedical Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing